We expect shares to trade off on the elevated expenses though the stock market was arguably prepared for it with ... and 3.8% dividend yield. Amgen (AMGN): Reiterate outperform rating. Remain buyers after a solid fourth quarter beat and …
On Sunday, the world's largest independent biotechnology company, Amgen Inc. (Nasdaq: AMGN), bought Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) in a $10.4 billion dollar deal – making it the fifth-largest biotech deal in history …
"But giving the way the stock is reacting, maybe we're coming close to finding a bottom here." In the technology sector, Brady said Nokia has good fundamentals, so he's inclined to hold onto Nokia. He also said Amgen is a terrific company …
By Mr. Loeb’s reckoning, a breakup could yield significant results. Given its current corporate self-help plan, Amgen appears set to improve its stock’s valuation to $189 a share by the end of 2016. But if the company splits itself in two, …
traders are definitely monitoring Bristol-Myers Squibb’s price action to see if this move attracts further buying into the stock. Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company that develops, …